Side effects reported by European consumers for medications for erectile dysfunction
Objective: To characterise consumer adverse drug reaction (ADR) reports for phosphodiesterase type 5 (PDE5) inhibitors. Methods: We included ADR reports submitted by adults to the European ADR database (EudraVigialnce) from 2007 to 2011. ADRs were classified according to type, seriousness and age a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
| Series: | Journal of Research in Pharmacy Practice |
| Subjects: | |
| Online Access: | http://www.jrpp.net/article.asp?issn=2319-9644;year=2013;volume=2;issue=2;spage=93;epage=95;aulast=Aagaard |
| _version_ | 1818946972734717952 |
|---|---|
| author | Lise Aagaard Ebba Holme Hansen |
| author_facet | Lise Aagaard Ebba Holme Hansen |
| author_sort | Lise Aagaard |
| collection | DOAJ |
| description | Objective: To characterise consumer adverse drug reaction (ADR) reports for phosphodiesterase type 5 (PDE5) inhibitors.
Methods: We included ADR reports submitted by adults to the European ADR database (EudraVigialnce) from 2007 to 2011. ADRs were classified according to type, seriousness and age and sex of consumers. The unit of analysis was one ADR.
Findings: Totally, 328 ADRs were reported for sildenafil and vardenafil, and only 5% of these were serious. The largest number of reported ADRs was found for sildenafil, i.e., "lack of efficacy" and/or "drug efficacy decreased" ( n = 134) and "headache" ( n = 21).
Conclusion: ADRs reported by consumers for PDE5 inhibitors were relatively low, and only few ADRs were serious. |
| first_indexed | 2024-12-20T08:23:30Z |
| format | Article |
| id | doaj.art-7e30d486e44a48c7b2046cba5caee8ea |
| institution | Directory Open Access Journal |
| issn | 2319-9644 2279-042X |
| language | English |
| last_indexed | 2024-12-20T08:23:30Z |
| publishDate | 2013-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Research in Pharmacy Practice |
| spelling | doaj.art-7e30d486e44a48c7b2046cba5caee8ea2022-12-21T19:46:55ZengWolters Kluwer Medknow PublicationsJournal of Research in Pharmacy Practice2319-96442279-042X2013-01-0122939510.4103/2279-042X.117390Side effects reported by European consumers for medications for erectile dysfunctionLise AagaardEbba Holme HansenObjective: To characterise consumer adverse drug reaction (ADR) reports for phosphodiesterase type 5 (PDE5) inhibitors. Methods: We included ADR reports submitted by adults to the European ADR database (EudraVigialnce) from 2007 to 2011. ADRs were classified according to type, seriousness and age and sex of consumers. The unit of analysis was one ADR. Findings: Totally, 328 ADRs were reported for sildenafil and vardenafil, and only 5% of these were serious. The largest number of reported ADRs was found for sildenafil, i.e., "lack of efficacy" and/or "drug efficacy decreased" ( n = 134) and "headache" ( n = 21). Conclusion: ADRs reported by consumers for PDE5 inhibitors were relatively low, and only few ADRs were serious.http://www.jrpp.net/article.asp?issn=2319-9644;year=2013;volume=2;issue=2;spage=93;epage=95;aulast=AagaardAdverse drug reactions; consumers; erectile dysfunction; EudraVigilance; pharmacovigilance |
| spellingShingle | Lise Aagaard Ebba Holme Hansen Side effects reported by European consumers for medications for erectile dysfunction Journal of Research in Pharmacy Practice Adverse drug reactions; consumers; erectile dysfunction; EudraVigilance; pharmacovigilance |
| title | Side effects reported by European consumers for medications for erectile dysfunction |
| title_full | Side effects reported by European consumers for medications for erectile dysfunction |
| title_fullStr | Side effects reported by European consumers for medications for erectile dysfunction |
| title_full_unstemmed | Side effects reported by European consumers for medications for erectile dysfunction |
| title_short | Side effects reported by European consumers for medications for erectile dysfunction |
| title_sort | side effects reported by european consumers for medications for erectile dysfunction |
| topic | Adverse drug reactions; consumers; erectile dysfunction; EudraVigilance; pharmacovigilance |
| url | http://www.jrpp.net/article.asp?issn=2319-9644;year=2013;volume=2;issue=2;spage=93;epage=95;aulast=Aagaard |
| work_keys_str_mv | AT liseaagaard sideeffectsreportedbyeuropeanconsumersformedicationsforerectiledysfunction AT ebbaholmehansen sideeffectsreportedbyeuropeanconsumersformedicationsforerectiledysfunction |